Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis.

Fenoglio C, Cantoni C, De Riz M, Ridolfi E, Cortini F, Serpente M, Villa C, Comi C, Monaco F, Mellesi L, Valzelli S, Bresolin N, Galimberti D, Scarpini E.

Neurosci Lett. 2011 Oct 17;504(1):9-12. doi: 10.1016/j.neulet.2011.08.021. Epub 2011 Aug 19.

PMID:
21875645
2.

Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients.

Lindberg RL, Hoffmann F, Mehling M, Kuhle J, Kappos L.

Eur J Immunol. 2010 Mar;40(3):888-98. doi: 10.1002/eji.200940032.

3.

miR-15a and 16-1 are downregulated in CD4+ T cells of multiple sclerosis relapsing patients.

Lorenzi JC, Brum DG, Zanette DL, de Paula Alves Souza A, Barbuzano FG, Dos Santos AC, Barreira AA, da Silva WA.

Int J Neurosci. 2012 Aug;122(8):466-71. doi: 10.3109/00207454.2012.678444. Epub 2012 May 1.

PMID:
22463747
4.

No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.

Akkız H, Bayram S, Bekar A, Akgöllü E, Usküdar O, Sandıkçı M.

Gene. 2011 Oct 15;486(1-2):104-9. doi: 10.1016/j.gene.2011.07.006. Epub 2011 Jul 23.

PMID:
21807077
5.

[Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma].

Zhang XW, Pan SD, Feng YL, Liu JB, Dong J, Zhang YX, Chen JG, Hu ZB, Shen HB.

Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Mar;45(3):239-43. Chinese.

PMID:
21624236
6.

Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.

Stagakis E, Bertsias G, Verginis P, Nakou M, Hatziapostolou M, Kritikos H, Iliopoulos D, Boumpas DT.

Ann Rheum Dis. 2011 Aug;70(8):1496-506. doi: 10.1136/ard.2010.139857. Epub 2011 May 20.

PMID:
21602271
7.

Differential microRNA expression in blood in multiple sclerosis.

Søndergaard HB, Hesse D, Krakauer M, Sørensen PS, Sellebjerg F.

Mult Scler. 2013 Dec;19(14):1849-57. doi: 10.1177/1352458513490542. Epub 2013 Jun 17.

PMID:
23773985
8.

miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.

Honardoost MA, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M.

Gene. 2014 Jul 10;544(2):128-33. doi: 10.1016/j.gene.2014.04.069. Epub 2014 Apr 30.

PMID:
24792898
9.

Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis.

Li J, Wan Y, Guo Q, Zou L, Zhang J, Fang Y, Zhang J, Zhang J, Fu X, Liu H, Lu L, Wu Y.

Arthritis Res Ther. 2010;12(3):R81. doi: 10.1186/ar3006. Epub 2010 May 11.

10.

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.

Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E.

PLoS One. 2009 Oct 13;4(10):e7440. doi: 10.1371/journal.pone.0007440.

11.

MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.

Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, Broadley S, Scott RJ, Booth DR, Lechner-Scott J; ANZgene Multiple Sclerosis Genetics Consortium.

PLoS One. 2010 Aug 11;5(8):e12132. doi: 10.1371/journal.pone.0012132.

12.

Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.

Haghikia A, Haghikia A, Hellwig K, Baraniskin A, Holzmann A, Décard BF, Thum T, Gold R.

Neurology. 2012 Nov 27;79(22):2166-70. doi: 10.1212/WNL.0b013e3182759621. Epub 2012 Oct 17.

PMID:
23077021
13.

Genetic association of MiR-146a with multiple sclerosis susceptibility in the Chinese population.

Li Y, Du C, Wang W, Ma G, Cui L, Zhou H, Tao H, Yao L, Zhao B, Li K.

Cell Physiol Biochem. 2015;35(1):281-91. doi: 10.1159/000369695. Epub 2015 Jan 10.

14.

Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.

Waschbisch A, Atiya M, Linker RA, Potapov S, Schwab S, Derfuss T.

PLoS One. 2011;6(9):e24604. doi: 10.1371/journal.pone.0024604. Epub 2011 Sep 16.

15.

Genetic study of two single nucleotide polymorphisms within corresponding microRNAs and susceptibility to tuberculosis in a Chinese Tibetan and Han population.

Li D, Wang T, Song X, Qucuo M, Yang B, Zhang J, Wang J, Ying B, Tao C, Wang L.

Hum Immunol. 2011 Jul;72(7):598-602. doi: 10.1016/j.humimm.2011.03.004. Epub 2011 Apr 12. Erratum in: Hum Immunol. 2012 Jan;73(1):140. Li, Dingdong [corrected to Li, Dongdong].

PMID:
21524676
16.

MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N.

Arthritis Rheum. 2009 Apr;60(4):1065-75. doi: 10.1002/art.24436.

17.

Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.

Pulkkinen K, Luomala M, Kuusisto H, Lehtimäki T, Saarela M, Jalonen TO, Elovaara I.

Acta Neurol Scand. 2004 May;109(5):342-7.

PMID:
15080861
18.

miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.

Ahmadian-Elmi M, Bidmeshki Pour A, Naghavian R, Ghaedi K, Tanhaei S, Izadi T, Nasr-Esfahani MH.

Immunogenetics. 2016 Jan;68(1):43-54. doi: 10.1007/s00251-015-0881-y. Epub 2015 Nov 13.

PMID:
26563334
19.

The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.

Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG, Zhang L.

Breast Cancer Res Treat. 2011 Jan;125(2):571-4. doi: 10.1007/s10549-010-0993-x. Epub 2010 Jul 17.

PMID:
20640596
20.

Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.

Gillett A, Thessen Hedreul M, Khademi M, Espinosa A, Beyeen AD, Jagodic M, Kockum I, Harris RA, Olsson T.

Mult Scler. 2010 Sep;16(9):1056-65. doi: 10.1177/1352458510364634. Epub 2010 Mar 30.

PMID:
20354066

Supplemental Content

Support Center